Le Lézard
Classified in: Health, Science and technology
Subject: PLW

U.S. Patent and Trademark Office Issues Seventh Gunshot Detection Patent to Shooter Detection Systems

New patent awarded for cable-free (wireless) indoor gunshot detection sensors to SDS.

ROWLEY, Mass., Jan. 9, 2023 /PRNewswire-PRWeb/ -- Shooter Detection Systems (SDS), an Alarm.com (NASDAQ: ALRM) company and the world's leading gunshot detection solutions provider, today announced the issuance by the USPTO of SDS' seventh patent for its gunshot detection technology, Patent No. US 11,417,183 titled Cable-Free Gunshot Detection.

The patent describes the application of indoor gunshot detection sensors that use a cable-free device powered by a battery. The foundational concepts and designs in this patent are currently offered by SDS as their Guardian Wireless product, a dual mode acoustic and infrared gunshot detection sensor that has been on the market since 2019. This patent builds on earlier SDS patents, specifically US 10,657,800 B1 titled Gunshot Detection Within an Indoor Environment, which focused on techniques for privacy-centric gunshot detection in an indoor environment utilizing two-factor authentication. The Guardian Wireless product has allowed SDS to achieve commercial success by meeting its goal of lowering overall customer costs by as much as 40-60 percent via reductions in overall project infrastructure costs.

Unlike some manufacturers whose patents do not directly relate to gunshot detection sensor technology, or focus only on single-factor acoustic detection, SDS's patent portfolio reflects its long-term dedication to advancing the technical state of the art while delivering highly reliable, cost-effective solutions to the market. Additional technical advances developed by SDS and described in the new patent include high-level ambient lighting filtering in complex lighting environments, and advanced data processing techniques in the cable-free sensor to improve processing speeds and battery life.

"SDS works tirelessly to give our customers the most accurate, value-driven solution on the market today," said Richard Onofrio, SDS' Managing Director, member of the sensor design team and co-author of the patent with Ronald Fowler, Chief Technology Officer for SDS. "I am extremely proud of our entire engineering team. A strong patent portfolio demonstrates unequivocally to experts, clients, and investors that SDS is the industry leader in this domain."

"Not all technical advances are patentable," added Ronald Fowler. "The innovations that our team has made clearly deserve the attention and recognition that comes when a US patent is awarded."

This patent marks the seventh gunshot detection patent owned by SDS, following its 2020 patent for techniques for indoor gunshot sensor testing. SDS invites its partners, competitors and the public to view its technical advance on the company's patent page.

About Shooter Detection Systems
With over eight years of experience in the development and delivery of gunshot detection systems to commercial customers, Shooter Detection Systems (SDS), an Alarm.com (Nasdaq: ALRM) company, is a leading provider of patented gunshot detection solutions for schools, government buildings, transportation hubs, entertainment facilities and businesses of many sizes. For more information, visit ShooterDetectionSystems.com or call 1-844-SHOT911. Follow SDS social channels on Twitter @ShooterDetect and on LinkedIn.

Media Contact

Kendra Noonan, Shooter Detection Systems, 844-746-8911, [email protected]


SOURCE Shooter Detection Systems

These press releases may also interest you

at 08:00
In Cohort 3, after 4 weeks of once-daily 100 mg dosing with the investigational, oral covalent menin inhibitor, BMF-219, 89% of patients achieved a reduction in A1c, 78% of patients achieved at least a 0.5% reduction in A1c, and 56% achieved at least...

at 08:00
Scientist.com, the premier R&D marketplace for the biopharmaceutical industry, announced today that Selvita (WSE: SLV) will be participating in its new IND Package Pipeline Program. The program provides a commercial framework that enables researchers...

at 07:50
Avicanna Inc. ("Avicanna" or the "Company) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that Shoppers Drug Mart® ("Shoppers") has...

at 07:50
Evaxion Biotech A/S ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the discovery and development of AI-powered...

at 07:50
Shoppers Drug Mart today announced plans to transition its Medical Cannabis by Shoppers business to Avicanna, one of Canada's leading biopharmaceutical companies. Over the next three months, Shoppers will continue to support patients throughout the...

at 07:35
Sonoma Biotherapeutics, Inc. and Regeneron Pharmaceuticals, Inc. today announced a collaboration to apply their scientific and clinical expertise and respective technology platforms to the discovery, development and commercialization of novel...

News published on 9 january 2023 at 08:00 and distributed by: